Related Experiment Video
Updated: May 7, 2026

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
Published on: January 27, 2023
Delta-opioid receptors attenuate TNF-α-induced MMP-2 secretion from human ONH astrocytes
Naseem Akhter1, Melissa Nix, Yasir Abdul
1Hewitt Laboratory of the Ola B. Williams Glaucoma Center, Department of Ophthalmology, Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina.
Purpose:
We examined the signaling mechanisms involved in δ-opioid-receptor agonist, SNC-121-mediated attenuation of TNF-α-induced matrix metalloproteinase-2 (MMP-2) secretion from human optic nerve head (ONH) astrocytes.
Methods:
Human ONH astrocytes were treated with SNC-121 (1 μmol/L) for 15 minutes followed by TNF-α (25 ng/mL) treatment for 6 or 24 hours. Cells were pretreated with inhibitors of p38 mitogen-activated protein (MAP) kinase (SB-203580) or NF-κB (Helenalin) prior to TNF-α treatment. Changes in phosphorylation and expression of p38 MAP kinase, IκBα, NF-κB, and MMP-2 were measured by Western blotting. Translocation of NF-κB was determined by immunocytochemistry.
Results:
TNF-α treatment increased MMP-2 secretion from ONH astrocytes to 236% ± 17% and 142% ± 8% at 6 and 24 hours, respectively; while SNC-121 treatment reduced MMP-2 secretion to 149% ± 11% and 108% ± 7% at 6 and 24 hours, respectively. The SNC-121-mediated inhibitory response was blocked by the δ-opioid-receptor antagonist naltrindole. TNF-α treatment resulted in a sustained phosphorylation of p38 MAP kinase up to 24 hours (226% ± 15% over control levels), which was reduced to 150% ± 20% by SNC-121 treatment. TNF-α treatment increased the expression of NF-κB to 179% ± 21% and 139% ± 6% at 6 and 24 hours, respectively, which was significantly blocked by SNC-121 treatment. Furthermore, TNF-α-induced MMP-2 secretion was blocked by 100% and 78% in the presence of SB-203580 and Helenalin, respectively.
Conclusions:
Evidence is provided that SNC-121 attenuated TNF-α-induced MMP-2 secretion from ONH astrocytes. Data also supported the idea that p38 MAP kinase and NF-κB played central roles in TNF-α-induced MMP-2 secretion, and both were negatively regulated by SNC-121.
Insights
The delta-opioid receptor agonist SNC-121 reduces tumor necrosis factor-alpha (TNF-α)-induced matrix metalloproteinase-2 (MMP-2) secretion in optic nerve head astrocytes. This effect involves the p38 MAP kinase and NF-κB signaling pathways.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Background:
- Tumor necrosis factor-alpha (TNF-α) can induce matrix metalloproteinase-2 (MMP-2) secretion.
- MMP-2 plays a role in optic nerve head (ONH) remodeling and disease.
- Understanding the regulation of MMP-2 secretion is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate the signaling mechanisms by which the delta-opioid receptor agonist SNC-121 attenuates TNF-α-induced MMP-2 secretion from human ONH astrocytes.
- To determine the involvement of p38 mitogen-activated protein (MAP) kinase and nuclear factor-kappa B (NF-κB) signaling pathways in this process.
Main Methods:
- Human ONH astrocytes were treated with SNC-121 and/or TNF-α.
- Inhibitors of p38 MAP kinase (SB-203580) and NF-κB (Helenalin) were used to block signaling pathways.
- Western blotting was employed to measure protein phosphorylation and expression.
- Immunocytochemistry was used to assess NF-κB translocation.
Main Results:
- SNC-121 significantly reduced TNF-α-induced MMP-2 secretion from ONH astrocytes.
- The inhibitory effect of SNC-121 was blocked by the delta-opioid receptor antagonist naltrindole.
- TNF-α treatment increased p38 MAP kinase phosphorylation and NF-κB expression, which were attenuated by SNC-121.
- Inhibitors of p38 MAP kinase and NF-κB blocked TNF-α-induced MMP-2 secretion.
Conclusions:
- SNC-121 effectively attenuates TNF-α-induced MMP-2 secretion in human ONH astrocytes.
- The p38 MAP kinase and NF-κB signaling pathways are critical mediators of TNF-α-induced MMP-2 secretion.
- SNC-121 exerts its inhibitory effects through negative regulation of both p38 MAP kinase and NF-κB signaling.
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...